243 related articles for article (PubMed ID: 36702900)
1. Massively parallel knock-in engineering of human T cells.
Dai X; Park JJ; Du Y; Na Z; Lam SZ; Chow RD; Renauer PA; Gu J; Xin S; Chu Z; Liao C; Clark P; Zhao H; Slavoff S; Chen S
Nat Biotechnol; 2023 Sep; 41(9):1239-1255. PubMed ID: 36702900
[TBL] [Abstract][Full Text] [Related]
2. High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR-T cell therapy.
Ding R; Chao CC; Gao Q
Methods Cell Biol; 2022; 167():1-14. PubMed ID: 35152989
[TBL] [Abstract][Full Text] [Related]
3. Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells.
Glaser V; Flugel C; Kath J; Du W; Drosdek V; Franke C; Stein M; Pruß A; Schmueck-Henneresse M; Volk HD; Reinke P; Wagner DL
Genome Biol; 2023 Apr; 24(1):89. PubMed ID: 37095570
[TBL] [Abstract][Full Text] [Related]
4. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates.
Ling X; Chang L; Chen H; Gao X; Yin J; Zuo Y; Huang Y; Zhang B; Hu J; Liu T
Mol Cell; 2021 Nov; 81(22):4747-4756.e7. PubMed ID: 34648747
[TBL] [Abstract][Full Text] [Related]
5. Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo.
Park HM; Liu H; Wu J; Chong A; Mackley V; Fellmann C; Rao A; Jiang F; Chu H; Murthy N; Lee K
Nat Commun; 2018 Aug; 9(1):3313. PubMed ID: 30120228
[TBL] [Abstract][Full Text] [Related]
6. Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds.
Teng F; Li J; Cui T; Xu K; Guo L; Gao Q; Feng G; Chen C; Han D; Zhou Q; Li W
Genome Biol; 2019 Feb; 20(1):15. PubMed ID: 30717767
[TBL] [Abstract][Full Text] [Related]
7. Efficient multiplex CRISPR/Cpf1 (Cas12a) genome editing system in Aspergillus aculeatus TBRC 277.
Abdulrachman D; Champreda V; Eurwilaichitr L; Chantasingh D; Pootanakit K
J Biotechnol; 2022 Aug; 355():53-64. PubMed ID: 35788357
[TBL] [Abstract][Full Text] [Related]
8. In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens.
Chow RD; Wang G; Ye L; Codina A; Kim HR; Shen L; Dong MB; Errami Y; Chen S
Nat Methods; 2019 May; 16(5):405-408. PubMed ID: 30962622
[TBL] [Abstract][Full Text] [Related]
9. Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.
Zetsche B; Heidenreich M; Mohanraju P; Fedorova I; Kneppers J; DeGennaro EM; Winblad N; Choudhury SR; Abudayyeh OO; Gootenberg JS; Wu WY; Scott DA; Severinov K; van der Oost J; Zhang F
Nat Biotechnol; 2017 Jan; 35(1):31-34. PubMed ID: 27918548
[TBL] [Abstract][Full Text] [Related]
10. Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity.
Huang H; Huang G; Tan Z; Hu Y; Shan L; Zhou J; Zhang X; Ma S; Lv W; Huang T; Liu Y; Wang D; Zhao X; Lin Y; Rong Z
BMC Biol; 2022 Apr; 20(1):91. PubMed ID: 35468792
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering.
Hamilton JR; Tsuchida CA; Nguyen DN; Shy BR; McGarrigle ER; Sandoval Espinoza CR; Carr D; Blaeschke F; Marson A; Doudna JA
Cell Rep; 2021 Jun; 35(9):109207. PubMed ID: 34077734
[TBL] [Abstract][Full Text] [Related]
12. Multiplex gene editing and large DNA fragment deletion by the CRISPR/Cpf1-RecE/T system in Corynebacterium glutamicum.
Zhao N; Li L; Luo G; Xie S; Lin Y; Han S; Huang Y; Zheng S
J Ind Microbiol Biotechnol; 2020 Aug; 47(8):599-608. PubMed ID: 32876764
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
14. Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells.
Ma X; Chen X; Jin Y; Ge W; Wang W; Kong L; Ji J; Guo X; Huang J; Feng XH; Fu J; Zhu S
Nat Commun; 2018 Apr; 9(1):1303. PubMed ID: 29610531
[TBL] [Abstract][Full Text] [Related]
15. Efficient generation of locus-specific human CAR-T cells with CRISPR/cCas12a.
Ling X; Chang L; Chen H; Liu T
STAR Protoc; 2022 Jun; 3(2):101321. PubMed ID: 35496795
[TBL] [Abstract][Full Text] [Related]
16. Improved CRISPR-Cas12a-assisted one-pot DNA editing method enables seamless DNA editing.
Wang L; Wang H; Liu H; Zhao Q; Liu B; Wang L; Zhang J; Zhu J; Bao R; Luo Y
Biotechnol Bioeng; 2019 Jun; 116(6):1463-1474. PubMed ID: 30730047
[TBL] [Abstract][Full Text] [Related]
17. One-step generation of modular CAR-T cells with AAV-Cpf1.
Dai X; Park JJ; Du Y; Kim HR; Wang G; Errami Y; Chen S
Nat Methods; 2019 Mar; 16(3):247-254. PubMed ID: 30804551
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cpf1-mediated genome editing and gene regulation in human cells.
Li T; Zhu L; Xiao B; Gong Z; Liao Q; Guo J
Biotechnol Adv; 2019; 37(1):21-27. PubMed ID: 30399413
[TBL] [Abstract][Full Text] [Related]
19. The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells.
Mohr M; Damas N; Gudmand-Høyer J; Zeeberg K; Jedrzejczyk D; Vlassis A; Morera-Gómez M; Pereira-Schoning S; Puš U; Oliver-Almirall A; Lyholm Jensen T; Baumgartner R; Tate Weinert B; Gill RT; Warnecke T
ACS Synth Biol; 2023 Feb; 12(2):375-389. PubMed ID: 36750230
[TBL] [Abstract][Full Text] [Related]
20. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.
Schumann K; Lin S; Boyer E; Simeonov DR; Subramaniam M; Gate RE; Haliburton GE; Ye CJ; Bluestone JA; Doudna JA; Marson A
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10437-42. PubMed ID: 26216948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
